Black Diamond Therapeutics BDTX
NASDAQ BDTX
$2.08 +0.01 (+0.48%)
At close: Oct 21, 2026 · 4:00 PM EDT

Black Diamond Therapeutics (BDTX) Common Equity (2018 - 2026)

Updated

Black Diamond Therapeutics (BDTX) posted Common Equity of $96.09 million for Q2 2026, down 27.5% from $132.61 million a year earlier and down 7.9% from the prior quarter.

Analysis

Black Diamond Therapeutics (BDTX) Common Equity (2018 - 2026) Analysis & Trends

At the end of FY2025, Black Diamond Therapeutics' Common Equity came in at $112.21 million, up 34.7% from FY2024.

  • Annual Common Equity shows a five-year compound annual growth rate of -18.3% (FY2020 to FY2025).
  • In prior years, Black Diamond Therapeutics' Common Equity was $83.29 million in FY2024 (-28.7%), $116.74 million in FY2023 (+0.9%), $115.7 million in FY2022 (-40.9%) and $195.9 million in FY2021 (-36.3%).
  • The Q2 2026 figure stands as the lowest quarterly Common Equity since Q4 2024.
  • On a year-over-year basis, Common Equity increased in four of the last eight quarters, with growth averaging 1.2%.
  • The strongest year-over-year quarter for Common Equity in the past five years was Q1 2025, with growth of 35.7%; the weakest was Q2 2023, with a decline of 46.1%.
  • According to Business Quant data, Common Equity for the three prior quarters was $104.3 million (Q1 2026), $112.21 million (Q4 2025) and $126.15 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 33.88 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 84.97 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -5.94 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 41.98 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 41.95 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 50.37 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 11.69 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 11.83 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 85.49 Bn
10 Black Diamond Therapeutics 118.75 Mn -374.17 Mn - 96.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 96.09 Mn
Mar 31, 2026 104.30 Mn
Dec 31, 2025 112.21 Mn
Sep 30, 2025 126.15 Mn
Jun 30, 2025 132.61 Mn
Mar 31, 2025 141.52 Mn
Dec 31, 2024 83.29 Mn
Sep 30, 2024 97.43 Mn
Jun 30, 2024 110.52 Mn
Mar 31, 2024 104.31 Mn
Dec 31, 2023 116.74 Mn
Sep 30, 2023 134.32 Mn
Jun 30, 2023 82.20 Mn
Mar 31, 2023 98.19 Mn
Dec 31, 2022 115.70 Mn
Sep 30, 2022 133.23 Mn
Jun 30, 2022 152.37 Mn
Mar 31, 2022 172.56 Mn
Dec 31, 2021 195.90 Mn
Sep 30, 2021 218.95 Mn
API Access

Black Diamond Therapeutics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=BDTX&period=max&api_key=YOUR_API_KEY